Process Excellence for Pharmaceutical, Biotech & Medical Device
Organization: International Quality Productivity Center
Venue: Hilton Inn At Penn
|Event Date/Time: Feb 25, 2013 / 8:00 am - (EST)||End Date/Time: Feb 27, 2013 / 5:00 pm - (EST)|
Today, pharmaceutical manufacturers are focused, as never before, on reducing operational costs while ensuring compliance. Pressures are increasingly acute as many pharmaceutical manufacturers see a dwindling product pipeline, as well as greater competition from generics.
Potential world-wide cost savings from efficiency improvement could be as high as US$ 90 billion. While Research and Development (R&D) is generally considered a major cost center for the pharmaceutical industry, manufacturing accounts for 36%of a pharmaceutical manufacturer’s costs. The true cost of manufacturing becomes even more apparent when one considers the amount attributed to non-value-added activities and waste which is 80%and 50%.
Pharma and Biotech companies have seen a 25% reduction in R&D budgets backed by Downsizing of close to 1/3rd of the workforce increasing pressure on senior level executive to do “more with less”.
Riding on the success of a 13 year Lean Six Sigma event – We seek to broaden the scope and provide the industry with a 360 view discussing the critical challenges and addressing issues revolving around strategy deployment, change management, supply chain complexities, project management, building quality into manufacturing, R&D and product development processes